New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (Obinutuzumab) for Primary Membranous Nephropathy (pMN). Click here for more information. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Brian Kennedy

Brian Kennedy is a four-time Grammy Award–winning songwriter and producer, as well as a passionate advocate for rare kidney disease patients. Diagnosed with focal segmental glomerulosclerosis (FSGS) at the height of his music career, he later received a life-saving kidney transplant, an experience that now fuels his commitment to awareness, early detection, and health equity. Kennedy is the founder of Hits to Healing, a nonprofit dedicated to addressing health disparities through music, education, and community engagement. Drawing on both his personal journey and professional success, he brings a powerful voice and deep dedication to advancing NephCure’s mission.

Los Angeles, CA

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.